Background Heart failure, defined as a complex clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood, is a leading cause of mortality and hospitalization for adults older than 65 years in industrialized countries. The characteristics and outcome of patients with heart failure have been described by a number of previous epidemiological studies and large scale clinical trials, which have been performed mainly in the United States and Europe. Very little information is available on this issue in Japan.
Introduction
Heart failure (HF) is defined as a complex clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood according to the guidelines for the diagnosis and treatment of chronic heart failure of American College of Cardiology (ACC)/American Heart Association (AHA) and European Society of Cardiology (ESC). 1, 2 The cardiac manifestations of HF are dyspnea and fatigue, which may limit exercise tolerance, and fluid retention, which may lead to pulmonary congestion and peripheral edema. 1, 2 HF is a leading cause of morbidity and mortality in industrialized countries. 3 It is also a growing public health problem, mainly because of aging of the population and the increase in the prevalence of HF in the elderly. 4 The clinical characteristics, treatment, and outcome of these patients have been well described by a number of both community-based [5] [6] [7] and hospital-based studies, [8] [9] [10] [11] as well as by clinical trials of HF treatment. [12] [13] [14] However, information derived from clinical trials that is not necessarily representative of "real world" patients with HF.
Moreover, these studies have been performed mainly in the United States and Europe.
Very limited information is available on the characteristics and outcome of patients with HF in Japan. [15] [16] [17] Our previous studies were the first detailed analysis of clinical characteristics, management, and outcome including mortality and HFrelated readmission in Japan. [18] [19] [20] They demonstrated that HF patients were elderly, contained a larger population of women especially at higher age, had a higher incidence of overt HF despite a relatively normal ejection fraction (EF). As many as 35 % of hospitalized patients with HF were readmitted within 1 year of hospital discharge. These characteristics are consistent with those of patient population encountered in community-based studies reported previously. 21, 22 The Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD) is developed to provide a national prospective registry database describing the clinical characteristics, treatment, and outcomes of patients hospitalized due to the worsening of HF symptoms. It will also establish the framework for future initiatives to improve the outcomes of these patients. Specifically, this study is aimed to determine the influence of clinical characteristics on the patient outcomes and further identify the predictive risk of adverse outcomes. This report presents a detailed description of the rationale and design of JCARE-CARD. 
Methods

Study Design
JCARE-CARD is a multicenter registry designed to compile a large clinical database on the characteristics, management, and outcomes of patients hospitalized for the worsening of HF in Japan. Baseline data are collected during the episode of index hospitalization from January 2004 to June 2005. Follow-up data will be collected at least 1 year after the index admission.
Study Objectives
The specific objectives of the JCARE-CARD include the following: (1) to describe the demographic and clinical characteristics of hospitalized patients with HF in Japan; (2) to describe the in hospital and long-term outcomes; and (3) to identify the factors including specific treatments associated with improved or worsened outcomes.
Study Hospitals
The study hospitals include the cardiology units serving as primary, secondary, and tertiary referral medical centers for cardiovascular patients across Japan. They are authorized as the teaching hospitals by the Japanese Circulation Society.
Study Patients
For this registry, HF is defined as a complex clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood. The presence of HF was confirmed by using the Framingham criteria ( Table 1) . 5 Patients readmitted to the hospital during the study period are included only by the first hospitalization (index admission).
Patients must be at least 15 years old at the time of hospital admission. Eligibility is not contingent on the use of any particular therapeutic agent or regimen.
Data Collection and Processing
Data are entered using a web-based electronic data capture (EDC) system licensed by the JCARE-CARD (www.jcare-card.jp). The EDC system was chosen because of perceived advantages over the traditional, paper-based data entry process, including the ability to inform participating hospitals of missing or illogical data fields at the time of data submission. A study web site has been created with a public area providing general information regarding this study and a registry siteonly area that provides information concerning data registry (Figures 1 and 2) . The study hospitals are encouraged to register the patients as consecutively as possible.
The diagnosis of HF was established by the simultaneous presence of at least two major criteria or one major criterion in conjunction with two minor criteria by use of the Framingham criteria ( Table 1) . Compliance with these methods of registry is not strictly monitored.
For each case, baseline data recorded on the form include (1) demography;
(2) causes of HF; (3) precipitating causes; (4) comorbidities ; (5) complications; (6) clinical status; (7) electrocardiographic and echocardiographic findings; (8) treatment including discharge medications.
The status of all patients is surveyed at least 1 year after admission and the following information is obtained; (1) survival, (2) cause of death, and (3) the hospital readmission due to an exacerbation of HF that required more than continuation of their usual therapy on prior admission.
Patient Confidentiality
The JCARE-CARD protocol was organized to ensure compliance with the 
Statistical Analysis
Descriptive statistics are used to summarize baseline characteristics, treatment, and outcomes for the patients and for specific subgroups of interest.
Results
The JCARE-CARD enrolled HF patients from January 2004 to June 2005.
As of June 2005, baseline data on 2676 patients with HF have been registered from 164 participating hospitals (Figure 3 and Table 2 ).
Discussion
The characteristics and outcomes of patients with HF are poorly defined despite the public health importance of this disease. The JCARE-CARD, aimed to better characterize this population, is the first diverse, large-scale, prospective multicenter database of patients hospitalized for HF in Japan.
We have previously reported the characteristics and outcomes of patients admitted to the urban cardiology departments in Fukuoka, Japan. [18] [19] [20] These studies highlighted several important features of Japanese patients with HF. One key feature was the old age of HF patients. The mean age of HF patients was 69 years; 70 % were ≥ 65 years of age. Especially, women were mostly found in over 70 years. This is consistent with the previous community-based studies. 21, 22 Another important feature was the high proportion of patients with relatively preserved EF.
The half of patients with definite HF who had echocardiography had normal EF (≥ 50 %), indicating the contribution of diastolic dysfunction in the pathogenesis of HF. 20 Most interesting and important finding was a relatively good survival prognosis in our study patients; the 1-year mortality rate being 8.3 %. A survival prognosis of patients with decreased EF (< 40 %) was still good; the 1-year mortality rate being 9.1 %. At the first glance, this finding appears to be contradicted the generally held notion that advanced age and more comorbidity may be related to the poor survival. 18 In contrast to the relatively low mortality, rates of readmission for HF were as high as 40 % within 1 year after discharge. This value is comparable to those in prior studies (a 3-to 6-month readmission rate 30 to 50 %). 23, 24 The most commonly identified cause for hospital readmission was lack of compliance with medical and dietary treatment (48 %). 19 Even though our previous studies have provided a valuable insight into the clinical characteristics, outcomes, and the potential effective treatment strategies for HF patients in Japan, [18] [19] [20] the generalization of these results is questioned because our investigation was conducted in a small number of patients (n=230). Therefore, it is of critical importance to analyze the data of HF patients in routine clinical practice on a national basis and to form a database for future investigations. For The ADHERE is a registry designed to study characteristics, management, and outcomes in a broad sample of patients hospitalized with acute decompensated HF throughout the United States. 8 Participating hospitals identify patients with a were women. The most common comorbid conditions were hypertension (73%), coronary artery disease (57%), and diabetes (44%). Evidence of mild or no impairment of systolic function was found in 46% of patients. In hospital mortality was 4.0%. The ADHERE data provided important insights into the clinical characteristics and patterns of care of these patients. Similar to our previous studies, 20 the ADHERE demonstrated that many patients hospitalized with HF had mild or no impairment of systolic ventricular function. 27 These registry data demonstrates significant differences in the definition of HF between patients hospitalized due to HF and those enrolled in randomized clinical trials. 28 Even though JCARE-CARD and ADHERE share many similarities in the study design and rationale, there are several important differences between these registries. Follow-up data are not obtained in the ADHERE; therefore, the subsequent clinical outcome including death and readmission of patients after the index hospitalization is unknown. Data are gathered retrospectively after hospital discharge in the ADHERE, which may preclude prospective analysis of particular treatments in these patients.
Limitations
Several crucial limitations inherent in the design of the JCARE-CARD should be considered. First, the JCARE-CARD data are based on the decisions made by the participating cardiologists. The lack of a precise, universal definition of HF makes this type of registry difficult and open to many criticisms. However, it is not the objective of this survey to restrict enrollment to the narrowly defined population of HF usually included in clinical trials but rather to include a broad range of patients reflecting the current reality of clinical practice rather than trials. All participating hospitals are authorized as the teaching hospital by the Japanese Circulation Society. In addition, the information regarding the study protocol was regularly provided at the national as well as local meetings and also via monthly email notice. Second, this survey relies on the hospitals to volunteer their support.
This almost certainly biased the study towards larger centers, which could support research staff. In addition, we excluded other specialist wards than cardiology from this survey.
Conclusions
The JCARE-CARD will provide the first, valuable information on current patient characteristics, management, and outcomes in a broad sample of Japanese patients in routine clinical practice who are hospitalized with HF. These data may indicate that there are substantial opportunities to improve the efficiency of management for these patients. By helping to better characterize this disease state, it will ultimately have a significant impact on public health at the national level in Japan.
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